Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease

BACKGROUND: Perceived risks of hyperkalemia and acute renal insufficiency may limit use of mineralocorticoid receptor antagonist (MRA) therapy in patients with heart failure, especially those with diabetes mellitus or chronic kidney disease. METHODS AND RESULTS: Using clinical registry data linked t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Heart Assoc
Auteurs principaux: Cooper, Lauren B., Lippmann, Steven J., Greiner, Melissa A., Sharma, Abhinav, Kelly, Jacob P., Fonarow, Gregg C., Yancy, Clyde W., Heidenreich, Paul A., Hernandez, Adrian F.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5779000/
https://ncbi.nlm.nih.gov/pubmed/29275368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006540
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires